Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 2071 AL 2085

Lecanemab in Early Alzheimer's Disease

van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, Kanekiyo M, Li D, Reyderman L, Cohen S, Froelich L, Katayama S, Sabbagh M, Vellas B, Watson D, Dhadda S, Irizarry M, Kramer LD, Iwatsubo T.

N Engl J Med. 2023 Jan 5;388(1):9-21. doi: 10.1056/NEJMoa2212948. Epub 2022 Nov 29.

Challenges in the pharmacological treatment of patients under suspicion of chronic traumatic encephalopathy: A review

Roberta de Souza Mendes Kawamura L, Ferreira Lima Mota I, Santos Vasconcelos A, Renata Mortari M.

Brain Res. 2023 Jan 15;1799:148176. doi: 10.1016/j.brainres.2022.148176. Epub 2022 Nov 26.

Determinants of approved acetylcholinesterase inhibitor response outcomes in Alzheimer's disease: relevance for precision medicine in neurodegenerative diseases

Lista S, Vergallo A, Teipel SJ, Lemercier P, Giorgi FS, Gabelle A, Garaci F, Mercuri NB, Babiloni C, Gaire BP, Koronyo Y, Koronyo-Hamaoui M, Hampel H, Nisticò R; Neurodegeneration Precision Medicine Initiative (NPMI).

Ageing Res Rev. 2023 Feb;84:101819. doi: 10.1016/j.arr.2022.101819. Epub 2022 Dec 13.

Pharmacotherapy Evolution in Alzheimer's Disease: Current Framework and Relevant Directions

Miculas DC, Negru PA, Bungau SG, Behl T, Hassan SSU, Tit DM.

Cells. 2022 Dec 28;12(1):131. doi: 10.3390/cells12010131.

Aβ-Targeting Bifunctional Chelators (BFCs) for Potential Therapeutic and PET Imaging Applications

Krasnovskaya O, Kononova A, Erofeev A, Gorelkin P, Majouga A, Beloglazkina E.

Int J Mol Sci. 2022 Dec 23;24(1):236. doi: 10.3390/ijms24010236.

Pharmacologic treatment of depression in Alzheimer's disease

Haussmann R, Donix M.

Int Clin Psychopharmacol. 2023 Mar 1;38(2):81-88. doi: 10.1097/YIC.0000000000000439. Epub 2022 Nov 10.

Longitudinally Increasing Elevated Asymmetric Flortaucipir Binding in a Cognitively Unimpaired Amyloid-Negative Older Individual

Schwarz CG, Knopman DS, Ramanan VK, Lowe VJ, Wiste HJ, Cogswell PM, Utianski RL, Senjem ML, Gunter JR, Vemuri P, Petersen RC, Jack CR.

J Alzheimers Dis. 2022;85(1):59-64. doi: 10.3233/JAD-215052.

Mechanistic insight into the role of metformin in Alzheimer's disease

Sanati M, Aminyavari S, Afshari AR, Sahebkar A.

Life Sci. 2022 Feb 15;291:120299. doi: 10.1016/j.lfs.2021.120299. Epub 2022 Jan 7.

Psychotherapeutic interventions in individuals at risk for Alzheimer's dementia: a systematic review

Rostamzadeh A, Kahlert A, Kalthegener F, Jessen F.

Alzheimers Res Ther. 2022 Jan 31;14(1):18. doi: 10.1186/s13195-021-00956-8.

Blood-brain barrier leakage in Alzheimer's disease: From discovery to clinical relevance

Nehra G, Bauer B, Hartz AMS.

Pharmacol Ther. 2022 Jun;234:108119. doi: 10.1016/j.pharmthera.2022.108119. Epub 2022 Jan 30.

Role of melatonin in Alzheimer's disease: From preclinical studies to novel melatonin-based therapies

Roy J, Wong KY, Aquili L, Uddin MS, Heng BC, Tipoe GL, Wong KH, Fung ML, Lim LW.

Front Neuroendocrinol. 2022 Apr;65:100986. doi: 10.1016/j.yfrne.2022.100986. Epub 2022 Feb 12.

Cognition enhancing effect of rosemary (Rosmarinus officinalis L.) in lab animal studies: a systematic review and meta-analysis

Hussain SM, Syeda AF, Alshammari M, Alnasser S, Alenzi ND, Alanazi ST, Nandakumar K.

Braz J Med Biol Res. 2022 Feb 9;55:e11593. doi: 10.1590/1414-431X2021e11593. eCollection 2022.

Applications of artificial intelligence to aid early detection of dementia: A scoping review on current capabilities and future directions

Li R, Wang X, Lawler K, Garg S, Bai Q, Alty J.

J Biomed Inform. 2022 Mar;127:104030. doi: 10.1016/j.jbi.2022.104030. Epub 2022 Feb 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias